- Home
- VIVS vs CMND Comparison
VIVS vs CMND Comparison
Compare VIVS & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- CMND
- Stock Information
- Founded
- VIVS 2007
- CMND 2017
- Country
- VIVS United States
- CMND Canada
- Employees
- VIVS N/A
- CMND N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- VIVS Health Care
- CMND Health Care
- Exchange
- VIVS Nasdaq
- CMND Nasdaq
- Market Cap
- VIVS 4.7M
- CMND 5.3M
- IPO Year
- VIVS N/A
- CMND N/A
- Fundamental
- Price
- VIVS $2.51
- CMND $1.04
- Analyst Decision
- VIVS
- CMND
- Analyst Count
- VIVS 0
- CMND 0
- Target Price
- VIVS N/A
- CMND N/A
- AVG Volume (30 Days)
- VIVS 763.1K
- CMND 42.1K
- Earning Date
- VIVS 11-07-2025
- CMND 09-11-2025
- Dividend Yield
- VIVS N/A
- CMND N/A
- EPS Growth
- VIVS N/A
- CMND N/A
- EPS
- VIVS N/A
- CMND N/A
- Revenue
- VIVS $142,000.00
- CMND N/A
- Revenue This Year
- VIVS $42.38
- CMND N/A
- Revenue Next Year
- VIVS $15.42
- CMND N/A
- P/E Ratio
- VIVS N/A
- CMND N/A
- Revenue Growth
- VIVS 94.52
- CMND N/A
- 52 Week Low
- VIVS $1.41
- CMND $0.80
- 52 Week High
- VIVS $21.96
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- VIVS 63.18
- CMND 55.12
- Support Level
- VIVS $1.83
- CMND $1.00
- Resistance Level
- VIVS $3.10
- CMND $1.08
- Average True Range (ATR)
- VIVS 0.33
- CMND 0.04
- MACD
- VIVS 0.06
- CMND 0.00
- Stochastic Oscillator
- VIVS 57.25
- CMND 67.74
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.